Necrosis of muscular tissue is a serious consequence A new myotoxic phospholipase A 2 was isolated from of envenomation by snakebites (1). In envenomations the venom of the arboreal snake Bothriechis schlegelii caused by crotalid snakes of the genus Bothrops (Amer-(formerly Bothrops schlegelii) from Costa Rica, by ican lance-headed pit vipers), distributed from Mexico ion-exchange chromatography on CM-Sephadex. B. to Argentina, it has been shown that skeletal muscle schlegelii myotoxin I is a basic protein (pI ú 9.3) with necrosis develops mainly due to the action of basic toxa subunit molecular weight of 15 kDa, which migrates ins with group II phospholipase A 2 (PLA 2 ) 2 structure as a dimer in sodium dodecyl sulfate-polyacrylamide (reviewed in Ref. 2). In recent years, several species gel electrophoresis under nonreducing conditions. within the genus Bothrops have been reclassified into This myotoxin is recognized by antibodies generated the new genera Bothriechis, Bothriopsis, and Porthidagainst Bothrops asper myotoxin II (a lysine-49 phos-ium (3). The venoms of many of these species contain pholipase A 2 ), by both enzyme-immunoassay and gel basic PLA 2 myotoxins (4), which display sequence variimmunodiffusion, in the latter case with a pattern of ability (2, 5). Furthermore, several myotoxin variants partial identity. The toxin induces rapid myonecrosis or isoforms can exist in the venom of individual speciupon intramuscular injection in mice, as evidenced by mens, as shown in Bothrops asper (6). Given the sub- (10). In the present work, we describe the isolation and partial characterization of a myotoxic PLA 2 from this venom, named B. schlegelii myotoxin I.
MATERIALS AND METHODS
dissolved in 20 ml of PBS, was applied onto the surgically exposed Isolation of B. schlegelii myotoxin I. B. schlegelii venom was a cremaster of anesthetized mice, which was then covered with a thin pool obtained from more than 30 adult specimens collected in Costa sheet of Mylar, and the subsequent events were recorded during a Rica. After centrifugation, venom was lyophilized and stored at 45-min observation period, in three independent experiments. 040ЊC. Samples of 500 mg were dissolved in 10 ml of 0.05 M TrisImmunochemical studies. An enzyme immunoassay was utilized HCl, 0.1 M KCl, pH 7.0 buffer, and applied to a CM-Sephadex C-25 to screen B. schlegelii venom fractions from the CM-Sephadex for (Pharmacia, Sweden) column (30 1 2.5 cm) equilibrated with the the presence of components antigenically related to B. asper myotoxsame buffer. After collecting unbound proteins, elution of basic fracins. One hundred microliters of each fraction, diluted 1:50 in PBS, tions was carried out with a continuous linear gradient toward 0.75 was adsorbed onto Immulon-2 microplates (Dynatech, Virginia) over-M KCl, 0.05 M Tris-HCl, pH 7.0 buffer (11). Peaks were screened night. After five washings with PBS-0.05% Tween 20, plates were for PLA 2 activity and immunochemical cross-reactivity with rabbit blocked with 150 ml/well of PBS containing 10% fetal bovine serum antibodies against B. asper myotoxin II (4), as described below. On (FBS) for 1 h. After decanting, 100 ml/well of rabbit antiserum to B. the basis of these screenings, peak 5 was selected for further analysis. asper myotoxin II (diluted 1:1000 in PBS-2% FBS) was incubated It was rechromatographed identically, dialyzed exhaustively against for 1 h, followed by five washings and then by 100 ml/well of protein water, and lyophilized.
G-horseradish peroxidase conjugate (Sigma, 1:1000) for 1 h. Color Homogeneity. Toxin homogeneity was assessed by (a) polyacrylwas developed with 0.012% H 2 O 2 and o-phenylenediamine (2 mg/ml amide gel electrophoresis in the presence of sodium dodecyl sulfate in 0.1 M sodium citrate, pH 5.0), stopped with 2 M HCl, and recorded (SDS-PAGE) (12); (b) PAGE in the presence of urea, using a cathodic at 490 nm on a Dynatech MR5000 microplate reader. As a control, buffer system (13); (c) reverse-phase high-performance liquid chronormal rabbit serum was tested in parallel against each fraction. matography (RP-HPLC) using a Vydac C4 column eluted at 1 ml/ Finally, enzyme immunoassay readings for each fraction were supermin with a gradient from 0 to 80% acetonitrile in 0.1% trifluoroacetic imposed onto the chromatographic profile (absorbance at 280 nm) acid, using a Varian (Inert 9012) instrument; and (d) cation-exchange for the identification of cross-reactive peaks (18). HPLC using a Poros (Perseptive Biosystems) column eluted at 3 ml/ Antigenic cross-reactivity between the final preparation of B. min with a gradient from 0 to 1 M NaCl in 0. 18 g). Deaths were scored 48 h after injection, and the 50% lethal Prefocusing was performed for 250 V-h at 750 V, whereas final focusdose (LD 50 ) was estimated by the Spearman-Karber method (20) . ing was at the same voltage for 800 V-h. Isoelectric point marker Anticoagulant activity. Platelet-poor plasma from sheep was preproteins (Pharmacia, pH range 3-10) were run in parallel with B. pared by centrifuging citrated blood twice at 1000g at 5ЊC. For the schlegelii myotoxin I (20 mg). assay, 0.5 ml of plasma was incubated with varying amounts of toxin N-terminal sequencing. B. schlegelii myotoxin I was carboxy-dissolved in 0.1 ml of PBS, for 10 min at 37ЊC. Then, 0.1 ml of 0.25 methylated as previously described (14) and sequence analysis was M CaCl 2 was added and the coagulation time recorded. As a control, performed using an Applied Biosystems 470A instrument (Foster plasma aliquots were incubated in parallel with 0.1 ml of PBS. City, CA). Homology searches were done in the PIR and Swiss-Prot Edema-forming activity. Groups of five mice (18-20 g) received databases.
a subcutaneous injection of varying amounts of toxin, dissolved in Phospholipase A 2 activity. For qualitative screening of fractions, 50 ml of PBS, in their right footpad. After 1 h, edema was estimated an indirect hemolytic gel diffusion technique was utilized (15). by measuring the increase in footpad thickness with a low-pressure Washed sheep red blood cells (final concentration 1.2% v/v) were spring caliper (21) . Control mice received an injection of 50 ml of PBS. mixed at 45ЊC with 1% agarose in 0.12 M NaCl, 0.04 M sodium phosIn another experiment, the time course of edema was determined by phate buffer (PBS), pH 7.2, containing 1% egg yolk as a source of injecting a fixed dose of toxin (25 mg) similarly and measuring the phospholipids. The mixture was poured into plastic trays and cooled, footpad thickness at 1, 3, 6, 12, and 24 h. The involvement of different and then samples of 15 ml were loaded into wells made in the gel inflammatory mediators in the edema induced by B. schlegelii myoand allowed to diffuse for 16 h at 37ЊC for the measurement of the toxin I was evaluated by pretreating mice with an intraperitoneal lytic halo diameter. To exclude direct hemolytic activity, samples injection of diphenhydramine (25 mg/kg) or indomethacin (10 mg/ were assayed in parallel gels devoid of egg yolk. For quantitative kg), 1 h before the injection of 5 mg of toxin into the footpad. determination of PLA 2 activity, samples of 0.1 ml were incubated with 1.0 ml of egg yolk suspension (diluted 1:5 in 0.1 M Tris-HCl, 0.01 M CaCl 2 , pH 8.5) containing 1% Triton X-100, for 15 min at RESULTS 37ЊC. Then, the free fatty acids were extracted and titrated according Sephadex at pH 7.0 resulted in a major unbound peak Myotoxic activity. Varying amounts of toxin, dissolved in 50 ml of PBS, were injected into groups of five Swiss mice (18-20 g), in their of acidic components, followed by several smaller peaks right gastrocnemius muscle. A control group received 50 ml of PBS. of basic components eluted by the salt gradient ( Fig.  After 3 h, tail blood samples were collected into heparinized capillary 1A). Of these, peak 5 showed a strong immunochemical tubes, and the plasma creatine kinase (CK; EC 2.7.3.2.) activity was cross-reactivity when screened with an antiserum determined by a colorimetric assay (Sigma No. 520). CK activity was against previously characterized myotoxins from B.
expressed in U/ml, where 1 U results in the phosphorylation of 1 nmol of creatine per minute at 25ЊC. To determine the time course asper venom (Fig. 1A) . PLA 2 activity of the basic fracof CK release in vivo, a fixed dose of B. schlegelii myotoxin I (80 mg) tions concentrated mainly in peaks 5 and 6 (data not was injected im into groups of five mice, which were bled after 1, 3, shown). Peak 5 was selected for further characteriza- 6 , and 24 h for plasma CK determination. In addition, the morphologtion and rechromatographed under the same condiical alterations induced by B. schlegelii myotoxin in skeletal muscle were analyzed by intravital microscopy, using the mouse cremaster tions. A single symmetrical peak was obtained ( The toxin induced a dose-dependent myonecrosis upon im injection in mice, as evidenced by the significant increase in plasma CK activity (Fig. 5A) . CK levels increased since the first hour after injection, reached a maximum at 3 h, and declined to normal after 6 h (Fig. 5B) . At 3 h, the plasma CK activity represented a 12-fold increase over control levels, at a dose of 80 mg (Fig. 5A) .
By intravital microscopy, damage to skeletal muscle fibers was evidenced as soon as 4-6 min after exposure to the toxin. The first observed effect, starting within the first minute, was the induction of slow, transient contractions of the muscle fibers, which significantly distorted the whole tissue and its microvasculature. These contractions ceased after about 30-60 s, and then evident damage to the muscle fibers followed. The damaged fibers developed initially small lesions which were gradually enlarged by the slow retraction of the myofibrils in opposite directions. This retraction finally produced a complete transverse rupture of the fiber, with a general disorganization of intracellular contents in the lesion borders and their vicinity. This process was sometimes repeated at several points along a given muscle fiber, leaving at the end several ruptured seg- 1B). This protein appeared as a single band of 15 kDa in SDS-PAGE, after reduction by 2-mercaptoethanol ( Fig. 2A) . In the absence of reducing agent and heating, it migrated as a single band of an apparent mass of 21 kDa (not shown). In cathodic urea-PAGE the protein also appeared as a single component, with a mobility identical to a major band of the basic components of crude venom (Fig. 2B) . By both analytical RP-HPLC (Fig. 3A) and cation-exchange HPLC (Fig. 3B), the puri-FIG. 2 shown in Fig. 4 . In gel immunodiffusion, the toxin was (Fig. 2C) .
. Electrophoretic and immunodiffusion analyses of

B. asper myotoxins I and II
AID ABB 9865
/ 6b2b$$$101 02-12-97 08:04:36 arca PLA 2 activity on egg yolk phospholipids (4.2 mEqr mg 01 rmin 01 ). When individual tubes collected from the CM-Sephadex rechromatography of the toxin were analyzed for both PLA 2 and indirect hemolytic activities, and then superimposed to the protein content profile of the fractions, a slight displacement to the left was observed (Fig. 1B) .
In vitro, B. schlegelii myotoxin I showed a low anticoagulant activity on sheep platelet-poor plasma (Fig. 6) . On the other hand, it was devoid of procoagulant activity and exerted lethal activity upon intravenous injection, with an estimated LD 50 of 2.5 mg/g. It also induced a significant edema in mice, at doses as low as 2.5 mg/ footpad (Fig. 7A) . The edema was of rapid onset and was sustained for at least 6 h, then gradually resolving (Fig. 7B) . Pretreatment of mice with diphenhydramine or indomethacin did not modify significantly the course of footpad edema induced by 5 mg of the toxin (data not shown).
DISCUSSION
The isolation and properties of a myotoxic PLA 2 from the venom of B. schlegelii are presented in this study. Earlier reports on the ability of this venom to induce myonecrosis (8, 9), together with the observation of its antigenic cross-reactivity with antibodies against previously characterized myotoxic PLA 2 s from B. asper (10), prompted the search for this new myotoxin. Cat- HPLC, and cation-exchange HPLC.
Biochemical analyses indicated that B. schlegelii myotoxin I is a basic protein (pI ú 9.3), with a subunit molecular weight of 15 kDa, occurring as a dimer. Its ments separated by spaces apparently devoid of cellular material. No hemorrhagic foci developed through-N-terminal amino acid sequence shows highest homology to snake venom myotoxins belonging to the family out the observation period.
B. schlegelii myotoxin I exerted a low, but detectable of so-called Lys-49 PLA 2 s. This suggests that B. AID ABB 9865 / 6b2b$$$101 02-12-97 08:04:36 arca a residue which might be important for the expression of myotoxicity, on the basis of PLA 2 sequence comparisons (27) . Lys-49 PLA 2 s are unable to catalyze phospholipid hydrolysis due to critical amino acid substitutions in their calcium-binding loop (28) . However, in some cases, Lys-49 proteins that exhibit a very low catalytic activity have been purified, and there has been a debate on whether this low activity is an intrinsic property of these proteins or a slight contamination with enzymatically active Asp-49 PLA 2 s present in the same venoms (2, (28) (29) (30) (31) (32) (33) (34) . In the case of B. schlegelii myotoxin I, a low PLA 2 activity was clearly detectable, despite its Nterminal sequence strongly suggesting that it may be a Lys-49 variant. While a combination of analytical electrophoretic and chromatographic techniques failed to show a contaminant, the PLA 2 activity of fractions obtained after CM-Sephadex rechromatography of the toxin evidenced a slight peak displacement when superimposed onto the protein profile. This result would favor the hypothesis of a minor contaminant being responsible for the low PLA 2 activity of the preparation, but the possibility of an intrinsic activity cannot be excluded. Molecular cloning and expression of snake venom Lys-49 myotoxins will be invaluable in clarifying this controversy on their catalytic activity. lar permeability (leading to significant edema without hemorrhage), and to cause death when injected by the intravenous route, albeit at relatively high doses. schlegelii myotoxin I might also be a Lys-49 PLA 2 . However, some amino acid residues of this toxin show
The morphological characteristics of myonecrosis indifferences when compared to Lys-49 myotoxins described so far. Of positions 5 and 11, which in Lys-49 PLA 2 s are invariantly occupied by Leu and Gln, respectively, only Leu-5 is conserved in B. schlegelii myotoxin I, since Gln-11 is replaced by Leu. In addition, the conserved Gly-22 is replaced by Ile, while Met-2 and Tyr-3 would represent new amino acid variants in this group, if future sequence studies confirm B. schlegelii myotoxin I to be a Lys-49 PLA 2 . At least two natural variants of Asp-49 other than Lys have been described, including Ser-49 and Arg-49, from the venoms of Vipera ammodytes (22) and Trimeresurus mucrosquamatus (23), respectively.
Elucidation of the complete sequence of B. schlegelii myotoxin I would be helpful to understand the structure-function relationship of these basic PLA 2 s. The FIG. 6 . Anticoagulant activity of Bothriechis schlegelii myotoxin I in vitro. Sheep platelet-poor plasma was incubated for 10 min at myotoxic site of these proteins has not been conclu-37ЊC with different amounts of myotoxin (l), and then the recalcifisively identified, despite some experimental evidence cation time was determined after the addition of CaCl 2 . Recalcificasuggesting the participation of their N-terminal a-helix tion time of the phosphate-buffered saline control is indicated by (᭺). (24, 25) and C-terminal cationic/hydrophobic sequence Results represent means of duplicates, where SD is smaller than the symbol size. (26) . B. schlegelii myotoxin I has the conserved Lys-7, AID ABB 9865 / 6b2b$$$101 02-12-97 08:04:36 arca lished data) and rapid cytolysis (35) , have been described. It has been proposed that the anticoagulant activity of Bothrops myotoxic PLA 2 s on platelet-poor plasma depends on their ability to penetrate bilayers and on enzymatic phospholipid degradation (2, 36, 37) . In the case of B. schlegelii myotoxin I, our present findings support this hypothesis, since it has low anticoagulant and PLA 2 activities.
The molecular basis of the myotoxic action of PLA 2 s from snake venoms is still largely unsolved. Further characterization of more natural myotoxin variants, in combination with the study of genetically engineered mutants, will provide valuable clues in this field of research.
